Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma.
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Huan
H
Tong
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Xiao
X
Li
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Bo
B
Wei
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China. Electronic address: shcqcdmed@163.com.
Chengwei
C
Tang
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D000068579:Celecoxib / Q000008:administration & dosage; D016461:Chemoembolization, Therapeutic / Q000379:methods; D006499:Hepatic Artery; D006801:Humans; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D010456:Peptides, Cyclic / Q000008:administration & dosage; D011379:Prognosis; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives; D016896:Treatment Outcome
D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D000068579:Celecoxib